ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
What does an antibiotic cost to develop? What is it worth? How to afford it?
Mirror Bacteria: An AMR threat of unprecedented magnitude
Modeling the value of an effective antibiotic — Megiddo et al.
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
De-risking vaccine development: Insights spanning decades of experience
FDA and EMA regulatory updates / Fireside chat during the 4th AMR Conference
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
IDSA White Paper on developing narrow-spectrum antimicrobials + editorial by G. Drusano
Lancet: 10-20-30 targets to address AMR by 2030
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
The 37,000-year view: Infections in Eurasia
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet